Quarterly report pursuant to Section 13 or 15(d)

Temporary Equity and Stockholders' Deficiency - Schedule of Share-based Compensation, Equity Instruments Other Than Options, by Exercise Price Range (Details)

v3.10.0.1
Temporary Equity and Stockholders' Deficiency - Schedule of Share-based Compensation, Equity Instruments Other Than Options, by Exercise Price Range (Details)
 9 Months Ended
Sep. 30, 2018
$ / shares
shares
Warrants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Number of Warrants 1,332,045
Warrants Exercisable, Number of Warrants 1,332,045
Range of Exercise Price 2.00 [Member] | Warrants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.00
Warrants Outstanding Exercisable Into, Description Common Stock
Warrants Outstanding, Number of Warrants 741,879
Warrants Exercisable, Weighted Average Remaining Life in Years 2 years 3 months 19 days
Warrants Exercisable, Number of Warrants 741,879
Range of Exercise Price 2.30 [Member] | Warrants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.30
Warrants Outstanding Exercisable Into, Description Common Stock
Warrants Outstanding, Number of Warrants 401,859
Warrants Exercisable, Weighted Average Remaining Life in Years 7 months 6 days
Warrants Exercisable, Number of Warrants 401,859
Range of Exercise Price 2.50 [Member] | Warrants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.50
Warrants Outstanding Exercisable Into, Description Common Stock
Warrants Outstanding, Number of Warrants 188,307
Warrants Exercisable, Weighted Average Remaining Life in Years 2 years 6 months
Warrants Exercisable, Number of Warrants 188,307